Promoter Ravi Agrawal releases pledge on 17.32 lakh Ajanta Pharma shares

Pledge ReleasedOwnership Changes View source PDF

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+7.3%1-day move

₹3191.00

prior close

₹3180.40

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.5+1.4+1.7+2.4+7.3+4.8+4.7+4.6+5.8+2.9+8.6———

Up moveDown movePending

AI summary

Ravi Agrawal, promoter (trustee Ravi Agrawal Trust), released pledge on 17,32,792 Ajanta Pharma shares on June 25, 2026. Release was across four lenders: Tata Capital (4.99 lakh), Deutsche Investments (1.78 lakh), Infina Finance (7.95 lakh), and Aditya Birla Capital (2.61 lakh). Reason cited: excess pledge. Post-release, pledged shares for this trust stand at 16.98 lakh (1.36%) out of 1.28 crore total holding (10.24%).

Likely market impact

Positive. Pledge release cuts encumbrance on this trust from 2.75% to 1.36% of capital, reducing financial risk on promoter holdings.